INTRODUCTION
Juvenile myelomonocytic leukemia (JMML) is an aggressive myeloid malignancy of childhood. This disorder is currently classified under myelodysplastic/ myeloproliferative neoplasms (MDS/MPN) in children by the World Health Organization (WHO) [1] . Hepatosplenomegaly, lymphadenopathy, and constitutional symptoms are the most common presenting features [2] . Even though central DI had been described in association with other myeloid malignancies of adults, it is rare in JMML. Niemeyer et al [2] described only one case with DI in a retrospective study of 110 JMML cases. Hasle et al [3] reported 43 JMML cases with monosomy 7 and two of them presented with DI. A review of previous local data of 21 JMML patients in Hong Kong showed that 3 of them had monosomy 7 but none of them was complicated with DI (Chan GCF, unpublished data). We describe here our first case of JMML patient with neurofibromatosis type 1 (NF1) and monosomy 7 who was complicated by central DI, and compare the clinical and laboratory features with those in the literature.
CASE REPORT
A previously healthy 8-year-old Indonesian girl was found to have leucocytosis, monocytosis, and mild anemia during an episode of acute diarrhea. An initial bone marrow study revealed increased myelomonocytic series which was compatible with a myeloproliferative disorder. A diagnosis of JMML was suspected. In the subsequent two months, she complained of progressive Fig. 1C and D) . Central DI was subsequently confirmed by biochemical and imaging studies. A diagnosis of central DI complicating JMML with monosomy 7 in a patient with NF1 was made, according to the WHO Classification [1] . Her polyuria resolved dramatically after commencing desmopressin (DDAVP). The patient was returned to her referring pediatrician, pending for an appropriate donor for hematopoietic stem cell transplantation (HSCT).
DISCUSSION
The association of central DI and myeloid malignancies has been uncommonly reported, even though peri-hypophyseal leukemic infiltrates were found in 46% of adult patients with acute leukemia at postmortem [5] . The onset of DI is variable, but usually occurs as a presenting feature of the myeloid malignancies [6] . The possible mechanisms include leukemic infiltration, leukostasis, thrombosis, fibrosis, infection, and hemorrhage in the hypothalamo-neurohypophyseal system [7] . In most patients the MRI findings are normal. Classical finding of disappearance of the physiological hyperintense signal, termed "bright spot", at the neurohypophysis is caused by the loss of the vasopressin-containing vesicles in the posterior pituitary. Thickened infundibulum is also seen in some reported cases [6, 7] . Loss of the bright spot at the posterior pituitary has been suggested to be related to leukemic infiltration.
Of note, cases of acute myeloid leukemia (AML)/MDS complicated by DI have been reported to be associated with abnormalities of chromosome 7 [monosomy Cytogenetic analysis also revealed monosomy 7 in our JMML patient, again supporting the postulation that this karyotypic change is one factor contributing to the development of DI. For patients with partial or complete monosomy 7, the neutrophil migration gene in 7q22~qter region is lost, which increases susceptibility to infection and may predispose patients to onset of DI [9] .
Moreover, because most circulating arginine vasopressin (ADH) is bound to the platelets, thrombocytosis related to dysthrombopoiesis in monosomy 7 and/or 3q21q26 syndrome may interfere with level and function of circulating ADH [10] .
Review of the English literature of pediatric myeloid malignancies and DI yielded nine cases (Table 1) [11] [12] [13] [14] [15] [16] [17] [18] [19] . Seven of these (78%) patients had DI at diagnosis of AML/MDS. Cytogenetic data were available in four patients, of whom monosomy 7 and/or inversion of chromosome 3 was most commonly detected.
Two patients had AML/MDS associated with NF1 and monosomy 7. Imaging studies were performed in five patients and only one patient had loss of pituitary bright spot and enhancement of infundibulum. Two of three patients, who underwent postmortem examination, had leukemic infiltration in the posterior pituitary and one patient had suspected destruction of the hypothalamic nuclei by either infarction or arachnoid infiltration. Only two of the nine patients (22%) achieved disease remission with resolution of DI. Interestingly, Harb et al [6] also found that reported cases of AML complicated by DI with monosomy 7 (n = 25) had a trend towards lower complete remission (CR) and survival rates than those with other chromosomal aberrations (n = 6). Furthermore, AML cases with monosomy 7 and DI had worse CR rate than AML with monosomy 7 but without DI.
In conclusion, DI is a rare but important complication of myeloid malignancies in both adults and children and tends to occur early in the disease course. It is closely associated with the karyotypic abnormality of monosomy 7. The pathophysiological link between DI and monosomy 7 is unclear. Whether the complication of DI has additional poor prognostic implication is difficult to assess because of the rarity of such cases and the inherent poor prognosis of myeloid malignancies associated with monosomy 7 or 3q21q26 rearrangement.
Nevertheless, it is important to recognize this unique complication in pediatric patients with myeloid malignancies and provide timely supportive treatment to prevent dehydration, electrolyte disturbances and aggravation of leukostasisrelated complications.
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